ClinicalTrials.Veeva

Menu

Generalized Seizure Detection And Alerting In The EMU With The Empatica Embrace Watch And Smartphone-Based Alert System

E

Empatica

Status

Unknown

Conditions

Epilepsy

Treatments

Device: Additional Seizure Monitoring

Study type

Interventional

Funder types

Industry

Identifiers

NCT03207685
2016-002

Details and patient eligibility

About

To demonstrate safety and effectiveness of the Embrace device in identifying convulsive seizures (CS) and notifying a caregiver during patient hospitalization at an epilepsy monitoring unit (EMU).

Full description

To demonstrate safety and effectiveness of the Embrace device in identifying convulsive seizures (CS) and notifying a caregiver during patient hospitalization at an epilepsy monitoring unit (EMU).

Subjects will be fit with an Embrace device upon admittance into the EMU. The Embrace system will be used in conjunction with the EMU standard care practices to monitor the subject during the subject's stay. EMU standard care practices will not be impacted by the Embrace system, but rather the Embrace will be used to supplement the EMU monitoring. The events detected by Embrace will later be compared to the gold standard results of the video EEG.

A convulsive seizure (CS) is defined for the purpose of this study as any seizure with non-facial motor activity involving one or both upper and/or lower extremities that has repetitive motor activity (rhythmic motor movements).

Enrollment

100 estimated patients

Sex

All

Ages

1+ month old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male and female patients with a history of convulsive seizure (as defined above) who are admitted to a hospital for routine vEEG monitoring related to seizures. Patients who are expected to have a convulsive seizure during their monitoring based on interpretation of clinical history.

Exclusion criteria

  • Patients who are not expected to have their typical convulsive seizure during the course of their hospital admission (i.e. expected reduction due to anti-epileptic drugs during hospital admission).
  • Women who are pregnant.
  • Patients who are known or suspected to have a history of PNES only.
  • Patients with known allergic reactions to nickel or stainless steel
  • Infants who were born pre-term and may not have fully developed skin

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

100 participants in 1 patient group

All Subjects
Other group
Description:
This is a single arm study With a device intervention of Additional Seizure Monitoring
Treatment:
Device: Additional Seizure Monitoring

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems